James Kaminski

7PUBLICATIONS
42CO-AUTHORS
Molecular targetsApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Cancer therapy (excl. chemotherapy and radiation therapy)Innate immunity
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Sep 02, 2026
PTPN2 Deletion Enhances CAR-T Effector Function and CNS Trafficking in a Non-Human Primate Model.

|Sep 26, 2025
PTPN2-KO CAR-T Cells Demonstrate Enhanced Effector Function, CNS Infiltration, and Toxicity in a Non-Human Primate CAR-T Model.

Francesca Alvarez Calderon, Ryan A Fleming, Marlana Winschel

|Mar 10, 2025
Graft-versus-host disease prophylaxis shapes T cell biology and immune reconstitution after hematopoietic cell transplant.

Steven J Siegel, Susan DeWolf, Joseph Schmalz

|Jan 29, 2025
Organ-specific microenvironments drive divergent T cell evolution in acute graft-versus-host disease.

Kayleigh Ingersoll Omdahl, Rene S Bermea, Ryan Fleming

|Apr 01, 2024
B-cell-directed CAR T-cell therapy activates CD8+ cytotoxic CARneg bystander T cells in patients and nonhuman primates.

James Kaminski, Ryan A Fleming, Francesca Alvarez-Calderon

|Feb 18, 2022
Batf-mediated epigenetic control of effector CD8+ T cell differentiation.

Hsiao-Wei Tsao, James Kaminski, Makoto Kurachi

Pageof 2

Frequent Collaborators

4 joint publications

Victor Tkachev

3 joint publications

Francesca Alvarez-Calderon

3 joint publications

Ulrike Gerdemann

3 joint publications

Lorenzo Cagnin